FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/08/2022
Voltar para busca
Dado oficial do USPTO
NOVOTECH HEALTH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NOVOTECH HEALTH
ST13
US500000079311087Classe
42
Pedido
79311087
Registro
6641668
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
16/08/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
26/10/2020
Data de registro
15/02/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/02/2022
Última transação
15/02/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
AU
Examinador
COLTON, BRITTANY
Unidade examinadora
N90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Novotech (Australia) Pty Ltd
Representantes
Matthew P. Hintz, Esq. Lowenstein Sandler LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
conducting clinical trials for others; conducting and managing clinical trials for others in the field of pharmaceuticalsbiotechnology and other related industries; conducting clinical trials for others scientific research; providing medical and scientific research information about the results of clinical trials in the nature of clinical trials for pharmaceuticals and biotechnology; scientific research; medical research; preparation of statisticsscientific analysis in the field of clinical trial results for scientific research; preparation of biostatisticsscientific analysis in the field of clinical trial results for scientific research in the fields of pharmaceuticalsbiotechnology and other related industries; provision of medical and scientific research information and data relating to medical and scientific research for pharmaceuticalsbiotechnology and other related industries; database design and development services to process data collected from clinical trials; medical research servicesmedical monitoring services for research in the fields of pharmaceuticalsbiotechnology and other related industries; quality auditsquality evaluation of site compliance with clinical trial protocols and standards; preparation of reports and applications to regulators relating to aspects of clinical trialsproviding medical and scientific information and data in the field of conducting clinical trials; provision of medical and scientific research information and data between scientistsmanufacturers and health authorities relating to pharmaceutical and biotechnology quality standardspreparation of reports and applications on the quality and standard of clinical trials; technical writing of clinical report forms which are required by clinical trial drug protocols
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
22/07/2022
FIMP
FINAL DISPOSITION PROCESSED
22/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
15/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/11/2021
PUBO
PUBLISHED FOR OPPOSITION
30/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
17/11/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
17/11/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/10/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
28/10/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/10/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
28/10/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/10/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2021
RFNT
REFUSAL PROCESSED BY IB
28/06/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/06/2021
RFRR
REFUSAL PROCESSED BY MPU
10/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/06/2021
CNRT
NON-FINAL ACTION WRITTEN
08/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
25/05/2021
DOCK
ASSIGNED TO EXAMINER
21/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NOVOTECH HEALTH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.